Personal information

No personal information available

Activities

Collapse all

Works (7)

Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis

Seminars in Arthritis and Rheumatism
2024-02 | Journal article
DOI: 10.1016/j.semarthrit.2023.152305
Contributors: L. van Ouwerkerk; S.A. Bergstra; T.D. Maarseveen; T.W.J. Huizinga; R. Knevel; C.F. Allaart
Source: check_circle
Crossref

Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

Annals of the Rheumatic Diseases
2024-01 | Journal article
DOI: 10.1136/ard-2023-224270
Contributors: Lotte van Ouwerkerk; Patrick Verschueren; Maarten Boers; Paul Emery; Pascal Hendrik Pieter de Jong; Robert BM Landewé; Willem Lems; Josef S Smolen; Tom WJ Huizinga; Cornelia F Allaart et al.
Source: check_circle
Crossref

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases
2023-04 | Journal article
DOI: 10.1136/ard-2022-223443
Contributors: Lotte van Ouwerkerk; Maarten Boers; Paul Emery; Pascal HP de Jong; Robert BM Landewé; Willem Lems; Josef S Smolen; Patrick Verschueren; Tom WJ Huizinga; Cornelia F Allaart et al.
Source: check_circle
Crossref

Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort

Scandinavian Journal of Rheumatology
2023-03-04 | Journal article
DOI: 10.1080/03009742.2022.2092269
Contributors: L van Ouwerkerk; D van der Woude; T Rispens; CF Allaart; TWJ Huizinga
Source: check_circle
Crossref

Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases
2022-07 | Journal article
DOI: 10.1136/annrheumdis-2022-222338
Contributors: Lotte van Ouwerkerk; Andriko Palmowski; Isabell S Nevins; Frank Buttgereit; Patrick Verschueren; Josef S Smolen; Robert BM Landewé; Johannes JW Bijlsma; Andreas Kerschbaumer; René Westhovens et al.
Source: check_circle
Crossref

Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugs

Annals of the Rheumatic Diseases
2021-10 | Journal article
DOI: 10.1136/annrheumdis-2021-219958
Contributors: Lotte van Ouwerkerk; Andrea E van der Meulen-de Jong; Maarten K Ninaber; Y K Onno Teng; Tom WJ Huizinga; Cornelia F Allaart
Source: check_circle
Crossref

Tapering of disease-modifying antirheumatic drugs: an overview for daily practice

The Lancet Rheumatology
2021-09 | Journal article
DOI: 10.1016/s2665-9913(21)00224-1
Part of ISSN: 2665-9913
Contributors: Johanna Maria Maassen; Lotte van Ouwerkerk; Cornelia Francina Allaart
Source: Self-asserted source
Lotte van Ouwerkerk via Crossref Metadata Search
How many people are using ORCID?